Baupost Group changed its filing status on Orexigen Therapeutics, Inc. (NASDAQ: OREX) to 13D from 13G. The hedge fund ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE